| Verifiedfields: | changed |
| Verifiedrevid: | 464387196 |
| Iupac Name: | 6-fluoro-1-(4-fluorophenyl)-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid |
| Cas Number: | 98105-99-8 |
| Atcvet: | yes |
| Atc Prefix: | J01 |
| Atc Suffix: | MA98 |
| Pubchem: | 56208 |
| Chemspiderid: | 50727 |
| Unii: | RC3WJ907XY |
| Chembl: | 37858 |
| C: | 20 |
| H: | 17 |
| F: | 2 |
| N: | 3 |
| O: | 3 |
| Smiles: | Fc1ccc(cc1)N\3c2cc(c(F)cc2C(=O)C(/C(=O)O)=C/3)N4CCNCC4 |
| Stdinchi: | 1S/C20H17F2N3O3/c21-12-1-3-13(4-2-12)25-11-15(20(27)28)19(26)14-9-16(22)18(10-17(14)25)24-7-5-23-6-8-24/h1-4,9-11,23H,5-8H2,(H,27,28) |
| Stdinchikey: | XBHBWNFJWIASRO-UHFFFAOYSA-N |
Sarafloxacin (INN) is a quinolone antibiotic drug,[1] [2] which was removed from clinical use by its manufacturer Abbott Laboratories from April 30, 2001.